Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery
Apply
TPIV100 & Sargramostim
TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step